The mechanism of neutropenia induction by tofacitinib is through the oxidation of tofacitinib to nitrenium ion by myeloperoxidase (MPO) in neutrophils, which reacts with sulfhydryl groups of cysteine residues of cellular proteins in leucocytes [9]. This evidence concerns the gene MPO and neutropenia.